High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
Authors
Keywords
Tuberculosis, Central nervous system, Meningitis, Pharmacokinetics, Blood plasma, Drug therapy, Randomized controlled trials, Therapeutic drug monitoring
Journal
PLoS One
Volume 14, Issue 3, Pages e0213718
Publisher
Public Library of Science (PLoS)
Online
2019-03-15
DOI
10.1371/journal.pone.0213718
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial
- (2018) Gustavo E Velásquez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
- (2018) Elin M Svensson et al. CLINICAL INFECTIOUS DISEASES
- Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
- (2018) Robin J Svensson et al. JOURNAL OF INFECTIOUS DISEASES
- Pound foolish and penny wise—when will dosing of rifampicin be optimised?
- (2018) Cecile Magis-Escurra et al. Lancet Respiratory Medicine
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- End TB with precision treatment!
- (2016) Evelien P.M. van der Burgt et al. EUROPEAN RESPIRATORY JOURNAL
- Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
- (2016) A. Dorothee Heemskerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
- (2015) Martin J. Boeree et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
- (2015) Alper Daskapan et al. EUROPEAN RESPIRATORY JOURNAL
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin
- (2014) C. Magis-Escurra et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model
- (2013) Jurriaan E. M. de Steenwinkel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculous meningitis: more questions, still too few answers
- (2013) Guy E Thwaites et al. LANCET NEUROLOGY
- Consequences of Noncompliance for Therapy Efficacy and Emergence of Resistance in Murine Tuberculosis Caused by the Beijing Genotype of Mycobacterium tuberculosis
- (2012) Jurriaan E. M. de Steenwinkel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- The impact of diabetes on tuberculosis treatment outcomes: A systematic review
- (2011) Meghan A Baker et al. BMC Medicine
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Therapeutic drug monitoring in the treatment of tuberculosis patients
- (2011) Cecile Magis-Escurra et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started